Skip to main content

Table 10 Hearing loss 3 months post first fitting compared to baseline: results of ANCOVA model applied for subgroup analyses by baseline hearing at 500 Hz air-conducted audiometry (> 65 dB or ≤ 65 dB)—ITT set

From: Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients

Subgroup

Effect

Estimate

Standard error

p value

95% confidence interval

Less or equal to 65 dB

ACEMg - placebo

− 11.46

9.1677502

0.2374

(− 31.63, 8.72)

Surgeon 2 - other surgeons

− 3.12

9.6611576

0.7529

(− 24.38, 18.15)

Flex 24 - Flex 20

23.26

13.8967484

0.1224

(− 7.33, 53.85)

Flex 28 - Flex 20

27.69

17.8852439

0.1498

(− 11.68, 67.06)

Flex 28 - Flex 24

4.43

12.9790722

0.7393

(− 24.14, 33.00)

More than 65 dB

ACEMg - placebo

− 1.89

4.4766332

0.6767

(− 11.07, 7.30)

Surgeon 2 - other surgeons

− 0.23

4.8327054

0.9623

(− 10.15, 9.69)

Flex 28 - Flex 24

13.09

8.2152402

0.1227

(− 3.77, 29.95)